Immediate Impact
3 from Science/Nature 55 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Open-ST: High-resolution spatial transcriptomics in 3D
2024 Standout
Works of Kyle McFarland being referenced
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes
2021
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Kyle McFarland | 255 | 102 | 59 | 187 | 158 | 8 | 396 | |
| Laura Todt | 261 | 120 | 47 | 156 | 145 | 8 | 425 | |
| Alexander K. Stewart | 289 | 199 | 68 | 134 | 69 | 7 | 410 | |
| Nicholas M. Fisher | 274 | 154 | 40 | 161 | 120 | 14 | 405 | |
| Catherine Spier | 168 | 108 | 57 | 167 | 149 | 10 | 381 | |
| K Ohishi | 134 | 162 | 46 | 81 | 123 | 11 | 381 | |
| Jenna D. Goldberg | 253 | 158 | 24 | 260 | 97 | 12 | 427 | |
| Paul Hoecker | 253 | 54 | 60 | 78 | 150 | 8 | 363 | |
| A Jacobs | 239 | 159 | 95 | 120 | 92 | 13 | 421 | |
| Emma L. Clarke | 316 | 56 | 85 | 175 | 106 | 12 | 429 | |
| Gurveen Saberwal | 170 | 236 | 67 | 114 | 107 | 13 | 413 |
All Works
Loading papers...